Prilosec OTC Approved In 28-, 42-Count Multiple Regimen Sizes
This article was originally published in The Tan Sheet
Executive Summary
FDA's June 20 approval of Procter & Gamble/ AstraZeneca's Prilosec OTC permits the companies to sell the proton pump inhibitor in packages containing more than one 14-day treatment regimen